Back to Search
Start Over
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study.
- Source :
- Cancer Communications; Feb2021, Vol. 41 Issue 2, p171-182, 12p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 25233548
- Volume :
- 41
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Cancer Communications
- Publication Type :
- Academic Journal
- Accession number :
- 148864556
- Full Text :
- https://doi.org/10.1002/cac2.12135